People
Researchers at a New York hospital compared Abbott’s 15-minute Abbott ID NOW test to another COVID-19 diagnostics device and found that the Abbott system missed 48% of positive cases the other device detected.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 14, 2020.
Following the announcement that Slaoui was tapped to helm Operation Warp Speed, Jim Greenwood, president and CEO of BIO, hailed that decision.
“VLPs have special immunological properties and are processed differently by the immune system so they have longer duration,” Adam Simpson, CEO of Icosavax, told BioSpace.
Although many cyber criminals have pledged not to attack healthcare providers during the COVID-19 pandemic, one expert tells CNBC that this may not extend to pharmaceutical companies.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 13, 2020.
The company plans to open a new 90,000 square foot facility this summer. It was a facility that VIVEX’s employees helped design in order to make it as efficient as possible.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 12, 2020.
The restructuring is related to the planned divestiture of Intrarosa (prasterone) and Vyleesi (bremelanotide injection) and the impact of the COVID-19 pandemic.
The government has added additional charges of conspiracy, wire fraud, and forfeiture.
PRESS RELEASES